This is the second in our Patient Centricity blog series. Read the first blog in the series, “What Does Patient Centricity Really Mean?” Pharmaceutical, biotech, medical device, and private medical facilities have been conducting clinical trials for decades, and over the years, the “bar” for medical…
Patient centricity is officially defined as the process of designing a service or solution around the patient. Sounds simple enough, right? For those of us in the clinical research space, it’s not always as simple as it would seem. The cultural mindset has to realign…
In June, I attended the Avoca Consortium summit in Dublin on behalf of Imperial. Representatives from more than 40 companies working in pharma and biotech attended, which was quite an achievement, especially considering that many of the delegates were juggling projects between major industry gatherings…
It’s common for sponsors and CROs to work with vendors to acquire ancillary supplies and ship them to sites. From the outset, it is important to fully understand your vendor’s capabilities and range of services to make sure you can attain your goals. Asking the…
We have found that many studies neglect to have plans in place regarding the Sunshine Act. Don’t overlook this! Sunshine Act reporting is required in clinical studies, and it should be included in planning your activities to ensure reporting compliance. The Sunshine Act, specifically…